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Congestive heart failure has become an incre&@ frequent 
reasonforhospiQla~durin~thc~2decpdosandderrly 
npresentsa~rlM!IdthplWblem.Dat?lfWltlWFkalUi@am 
HeartStudy~tbattbeinddenceofamgestiveheartfailure 
increaseswithageandisbigherinmenthaninwomen.Hyper- 
temionandcoromuyhemtdkasearethetwomostcommon 
conditions pndrrt& its onset. Diabetes mellitus and eleckowr- 
diograpldcleftventrkukhypcWophyarealsnassociatedwitb 
anhnzea&riskofkartfailm~.Duringthe1!J8Os,theanmud 
~ustedincidenceofcongestiveheartfailureamongpersons 
aged 245 years was 7.2 cases/l,000 in men and 4.7 cases/l,000 in 
Although there is no consensus on the criteria required to 
establish a diagnosis of congestive heart failure, it is clear 
that congestive heart failure represents a major health prob- 
lem. It has been estimated that congestive heart failure 
afilicts nearly 4 million Americans, with soO,ooO new cases 
each year (I). Congestive heart failure was listed as the 
principal cause for 37,400 deaths in 1988 and is thought to 
have been a contributing cause of another 200,OtM deaths 
(2,3). Data from the National Hospital Discharge Survey 
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- 
women, whereas the age-adjusted prevoience of ov rt heart hilure 
was 24/1,000 in men and 25/1,000 in women. Ikpite improved 
tr&Wnts ror ischemil! heart d&ease and hypertension, the 
age-adjusted incidence of heart failure has declined by only 
ll%/calendar decade in men and by 17Walendar decade in 
women during a 40-year period of observation. In addition, 
eve heart failure rem&s highly lethal, with a median 
s~~~eaf1.7yeus~menend3.2y~inwomenanda 
5-year survival rate of 25% in men and 38% in women. 
(J Am CoU Car&l 1993$2~trpplemeat A].&&13A) 
(4-8) showed a steady increase in the number of hospital 
admissions for congestive heart faihue during the last 2 
decades. For example, the rate of hospital discharges with a 
principal diagnosis of congestive heart faihue among Amer- 
icans 265 years increased from 7.5/1,0 in I%8 to l&3/ 
1 ,Oo in 1989 (4,7). 
In 1989,643,OOtl hospital discharges (2% of all discharges) 
carried aprincipal diagnosis ofcongestive heart failure (7. 
An additional 4% (1.2 million) of all discharges carried a 
secondary diinosis of congestive heart failure. Amon; 
patients 265 years, congestive h art faihue was the principal 
diagnosis n 5% of those discharged and a secondary diag- 
nosis in another 10%. The rate of hospital stays with any 
discharge diagnosis of congestive heart faihue increases 
dramatically with age, rising from 6.2/l ,008 in persons aged 
45 to 64 years to 47.411,OOtl in persons 265 years of age in 
1989. Women were mnre frequently admitted to the hospital 
for congestive heart fake than were men. In 1989, the rate 
of hospital dmissions with any discharge diagnosis ofCOD 
gestive heart failure was 6.811,Oog in men and 8/l,ooO in 
women; the rate of hospital admission with a principal 
diagnosis of congestive heart f ihue was 2.5/1,00 in men 
and 2.7/1,000 in women (7). 
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Methods 
In the Framingham Heart Study, we have had the oppor- 
tunity to examine the incidence, prevalence and prognosis of
congestive heart failure during four decades of bservation. 
Our study group was composed of participants in the 
Framingham Study and the Framingham Offspring Study. In 
1948,5,209 residents ofFramingham, Massachusetts aged 28 
to 62 years were enrolled in a prospective epidemiologic 
study. The selection criteria and study design have been 
reported elsewhere (9,lO). Members of this “original co- 
hort” have subsquently been evaluated at2-year intervals 
with medical history, physical examination a d laborator= 
tests. XII 19?!, children of the original study participants and
spouses of these children, aged 6 to 70 years, were entered in 
the Framingham Offspring Study (11). Serial evaluations 
were performed on members of the Framingham Offspring 
Study 8 and 12 years after enrollment. The 5,209 members of
the original cohort and the 5,135 members of the offspring 
cohort were eligible for inclusion in these analyszs. To avoid 
inclusion of overly high risk subjects in the offspring study, 
881 members of the offspring cohort with only one natural 
parent in the original cohort were excluded; such subjects 
were preferentially enrolled if that parent had a high risk 
lipid profile or premarure cardiovascular disease. Cases of 
congestive heart failure diagnosed at the tirst Framingham 
Heart Study examination were included in estimates ofheart 
failure prevalence but excluded from estimates of heart 
failure incidence. 
At each examination, interim cardiovascular disease 
events were identified by medical history, physical exami- 
nation, 12-lead electrocardiogram (ECG) and review of 
medical records. Hospital and physician records were ob- 
tained for participants who did not appear for an examina- 
tion. All possible cardiovascuhu events were reviewed by a 
committee of three physicians, using established Framing- 
ham Heart Study protocols and definitions (12,13). Coronary 
heart disease vents included angina pectoris, coronary 
insufficiency (unstable angina) and myocardial infarction 
(12). A patient was considered to have preexisting valvular 
heart disease if the examining physician oted a systolic 
murmur grade III/VI or louder, a diastolic murmur or a 
palpable thrill at any examination before the onset of heart 
failure. Radiographic and echocardiographic data were not 
used in the diagnosis of coronary or valvular heart disease. 
Elevated blood pressure was defined as a systolic blood 
pressure 2160 mm Hg or a diastolic blood pressure 
195 mm Hg on each of two successive determinations by a 
physician during a clinic examination. Hypertension was 
defined as the presence of ither elevated blood pressure or 
ongoing pharmacologic treatment of a previously elevated 
blood pressure. Subjects with a fasting blood glucose level 
27.77 mmoyliter (140 mg/dl) or a random blood glucose level 
85 1.10 mmol/liter (200 mg/dl) were considered .,I be dia- 
betic, as were individuals using insulin or oral hypoglycemic 
agents. Definite ECG left ventricular hypertrophy was diag- 
Table 1. Ckeria for Congestive H art Failure* 
Major criteria 
Paroxysmal noctutnal dyspnea 
Neck vein distension 
Rales 
Radiographic cardiomegaly @reasing heart size on chest X-ray film) 
Acute palmorary edema 
Third sound gallop 
Increased central wxous pressure (>I6 cm water at the right atrium) 
Ciitdation time 225 L 
Hepatojugular retlax 
Pulmonary edema, Gsceral congestion or cardiomegaly at autopsy 
Weigh loss 24.5 kg in 5 days in respottse to treat- of CfiF 
Minor Criteria 
Bilateral ankle edema 
Nocturnal coug!~ 
Dyspnea on ordinary exertion 
Hepatomegaly 
Plearal elf&n 
Decrease in vita) capacity by 33% from maximal value recorded 
Tachycardia (rate ~I20 beat&in) 
The diagnosis of congestive heart failure (CKF) required that two major 
or one major and two mittor criteria be present concarrently. Minor aiterkt 
were acceptable only if they could not be attriited to aaother medical 
condition. 
nosed if voltage criteria for left ventricular hypertrophy were 
fulfilled in an ECG exhibiting lateral ST segment depression 
or T wave flattening or inversion (13). 
Using information obtained at Fram&ham Heart Study 
examinations and from hospital and physician record:;. a
diagnosis of congestive h art faihm: was established bythe 
simultaneous presence of at least ro major or one major 
and two minor criteria for congestive heart failure (Table 1). 
Minor criteria were acceptable only if they couid not be 
attributed to another medical condition (12-14). The same 
criteria for congestive h art failure were used throughout the 
N-year follow-up eriod for these analyses. 
The incidence of congestive heart faihtre was estimated 
using the cross-sectional pooling method, with each 2-year 
interval between successive xaminations treated as an 
independent observation. Only individuals free of heart 
failure were included in a Zyear observation pool. Subjects 
who failed to appear for an examination were assigned 
“hypothetical” examination dates corresponding to their 
biennial anniversary dates; only information concerning 
interval cardiovascular disease events was attributed to 
these hypothetical examinations. Ail of the observations 
were further classified by the calendar year of the examina- 
tion and the age of the subject at the time of the visit. The 
relations between disease incidence and calendar yew, as 
well as between dichotomous risk factor measures and 
calendar year, were estimated using gender-specilic logistic 
regression analyses tratifying by 5-year age groups. A 
summary regression coefficient over all ages was derived by 
averaging the agespecific coefficients, using as weights the 
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inverse of their variances. The standard error of this sum- 
mary coefficient was calculated as the square root of the 
inverse of the sum of the weights. Some xtreme age groups 
(for example, age 40 or 290 years) were excluded from 
certain models because there w re too few observations to 
permit analysis. Age-adjusted differences in the proportion 
of cases of congestive heart failure with various antecedent 
conditions were examined by gender, using Cochran- 
Mantel-Xaenszel statistics tratified by 5-year age groups. 
For analysis of survival, Cox proportional hazards regres- 
sion models were employed to investigate he relations 
among survival, gender, age and calendar year at the time of 
first diagnosis ofcongestive heart f ilure. Because the study 
group was aging during the study period, in those models 
investigating the effect of calendar year, analyses were 
stratified by age at diagnosis (in S-year age groups); simi- 
larly, in those models evaluating age at diagnosis, analyses 
were stratilied by calendar year, expressed in half-decades. 
Except for the model exploring the effect of gender on 
survival, men and women were analyzed separately. Median 
survival times and survival rates at 90 days and at 1,2,4,5 
and 10 years after the diagnosis of congestive heart failure 
were estimated using Kaplan-Meier methods. To facilitate 
comparison with results from heart failure intervention tri- 
als, we repeated the survival analyses excluding subjects 
who died or were lost to follow-up during the 1st 90 days 
after the diagnosis of heart failure. Except where indicated, 
age-adjusted rates were obtained by direct adjustment to the 
United States 1991 population (15). The software package 
S-PLUS (Statistical Sciences, Inc.) was used for the survival 
analyses; all other computations were performed utilizing 
the SAS System (SAS Institute Inc.). A two-sided probabil- 
ity (p) value 5 0.05 was required for statistical significance. 
Numeric values are expressed as mean value + SD. 
ReSUltS 
Conges& heart lWlure ~poe& Among 9,405 Fmmingham 
Heart Study participants (47% male) followed up from Septem- 
ber 1948 to June 1988, congestive heart failure developed in
652. The mean age at the diagnosis ofheart failure was 70.0 f
10.8 years. These 331 men and 321 women were followed up 
for a median of 1.8 years after the diagnosis of congestive h art 
fails (mean 3.9 + 5.4 years; range 0 days to 35.8 years). 
There were 17 additional cases of congestive heart fake 
diagnosed atthe lkst Framingham Heart Study examination. 
Incidence of cungestlve h art failure. The incidence of 
congestive heart failure increased dramatically with age (Fig. 
1). The annual incidence increased from 3 cases/l ,000 in men 
aged 50 to 59 years to 27 cases/l ,000 in men aged 80 to 89. In 
women, the annual incidence increased from 2 cases/l ,000 in 
those 50 to59 years of age to 22 cases/l,000 in those 80 to 89 
years of age. The incidence of congestive heart failure was 
one-third lower in women than in men tier adjustment for 
age (age-adjusted od s ratio of women/men 0.6; 95% co& 
dence interval [CII 0.5 to 0.7). During the 198Os, the age- 
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Figure 1. Incidence rates of congestive h art failure (CHF) among 
Framingham Heart Study subjects, by gender and age. 
adjusted annual incidence of congestive heart failure was 
2.3 cases/l,000 inmen. In women, the corresponding age- 
adjusted annual incidence was 1.4 cases/l ,000. Among indi- 
viduals aged ~45 years, the age-adjusted annual incidence of 
congestive heart failure was 7.2 cases/l,000 in men and 
4.7 eases/1,000 in women. Analyses using logistic regression 
models revealed that the age-adjusted incidence of conges- 
tive heart failure in men decreased from 1948 to 1988 by 
1 l%/calendar decade (p < 0.05); in women, the age-adjusted 
incidence of congestive heart failure decreased by 17%/ 
calendar decade (p c 0.05) (16). 
Prevalence of heart fGlure. The prevalence of congesk 
heart failure also increased with age (Fig. 2). Among men, 
the prevalence ofheart failure climbed from 8 cases/l ,000 in 
those 50 to 59 years of age to 66 cases/l ,000 in those aged 80 
Figure 2. Prevalence rates of congestive h art failure (CHF) among 
Framingham Heart Study subjects, by gender and age. 
Men 
Women 
1 
39ci9 49.49 59-59 69-99 m-79 go-89 
Age (years) 
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Figure 3. Risk of congestive heart failure (CHF) in men in the 
Framingham Heart Study by age and risk factor status. Relative 
risks (RR) for the development of heart failure in the presence of the 
specified risk factor are displayed at the margins; values with 
asterisks are significant a p < 0.0001. Cholesterol =serum choles- 
terol >6.2 mmollliter (240 mg/dl); ECG-LVH = electrocardio- 
graphic left ventricular hypertrophy. 
to 89 years. In women, the prevalence of heart failure 
increased finm 8 cases/l,000 inthose aged 50 to 59 years to 
79 cases/l,000 in those 80 to 89 years of age. During the 
198Os, the age-adjusted prevalence ofcongestive heart fail- 
ure was 7.4/1,000 in men and 7.7/1,000 in women. Among 
individuals aged 145 years, the age-adjusted prevalence of
congestive heart f ilure was 2411,000 (or2.4%) in men and 
25/i ,000 (2.5%) in women. 
Risk factors for heart failure. Figures 3 and 4 demon- 
strate the risk of several conditions on the development of 
congestive heart f ilure. In men, a serum cholesterol level 
>6.2 mmol/liter (240 mgldl) was not associated with an 
increased risk of heart failure. Cigarette smoking increased 
the likeiihood of heart failure in younger, but not in older 
men. In younger men, hypertension a d diabetes mellitus 
were associated with a 4-fold increase in the incidence of 
heart failure and ECG left ventricular hypertrophy with a 
IS-fold increase. In men older than 65 years of age, the 
relative risks for heart failure associated with hypertension, 
diabetes and ECG left ventricular hypertrophy were less 
Figure 4. Risk of congestive h art failure (CHF) in women in the 
Framingham Heart Study by age and risk factor status. Relative 
risks (RR) for the development of heart failure in the presence ofthe 
specified risk factor are displayed at the m-s; values with 
asterisks are significant a p < 0.0001. Definitions as in Fiiure 3. 
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Figure 5. Prevalence of coronary heart disease (CHD) and hyper- 
tension (HTN) alone and in combination among Framingham Hean 
Study subjects with congestive h art failure, by gender. 
than those for younger men, but the excess risks were 
higher, reflecting reater absolute risk differences. In 
women, neither an elevated serum cholesterol level nor 
cigarette smoking resulted in an increased risk of heart 
failure. In younger women, hypertension was associated 
with a 3-fold increase in the incidence of heart failure, 
diabetes with an 8-fold increase and left ventricular hyper- 
trophy with a 13.fold increase. As in men, these three 
conditions were associated with higher excess risks but 
lower elative risks in older compared with younger women. 
Left ventricular hypertrophy was associated with an in- 
creased incidence ofheart failure, even after controlling for 
blood pressure. Similarly, the effect of diabetes was inde- 
pendent of concomitant hypertension or coronary heart 
disease. Other findings associated with an increased inci- 
dence of overt congestive heart f ilure included obesity, a 
high ratio of total cholesterol to high density lipoprotein 
cholesterol, proteinuria and ECG intraventricular conduc- 
tion disturbances or nonspecific repolarization abnormali- 
ties. 
Among the 331 men and 321 women in the Framingham 
Heart Study who developed congestive heart f ilure during 
the follow-up eriod, hypertension a d coronary heart dis- 
ease were the two most common preexisting conditions (Fig. 
5). Seventy percent of men and 78% of women with heart 
failure had an antecedent diagnosis of hypertension. Forty 
percent of men and women with heart failure had a prior 
history of both hypertension a d coronary heart disease. 
Prevalent coronary heart disease was less common in 
women than in men, with an odds ratio of 0.S after adjusting 
for age (95% CI 0.40 to 0.76); it was found in 59% of men and 
48% of women with new congestive heart failure. Eleven 
percent of men and 15% of women with heart failure had no 
prior history of hypertension or c ronary heart disease. 
The prevalence of several causes of and risk factors for 
heart failure are shown in Fire 6. Again, hypertension a d 
coronary heart disease were the two most prevalent co& 
tions in subjects with new heart failure. Recent cigarette 
smoking was less common in women than i  men, with an 
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Flgan 6. Prevalence of certain conditions among Framingham 
Heart Study subjects with congestive heart failure, by gender. 
ECG-LVH = electrocardiographic left ventricular hypertrophy. 
odds ratio of 0.51 after adjusting for age (95% CI 0.32 to 0.79); 
overall, 42% of men and 24% of women smoked cigarettes at
the time of the Framingham Heart Study examination imme- 
diately before the diagnosis of heart failure. Electrocardio- 
graphic left ventricular hypertrophy was noted before the 
diagnosis ofheart failure in 17% of men and 18% of women. 
After adjusting for age, only coronary heart disease and recent 
cigarette smoking were signihcantly less common in women 
than in men with new congestive h art failure. 
From 1948 to 1988, the age-adjusted prevalence ofcoro- 
nary heart disease among men with new congestive heart 
failure increased by 46%/calendar decade (p < 0.05). In 
contrast, the age-adjusted prevalence of coronary heart 
disease among all men in the Framingham Heart Study 
decreased by 8%/calendar decade (p < 0.05). The results 
were similar in women, who had an age-adjusted 46%/ 
calendar decade increase inthe prevalence of coronary heart 
disease among subjecrs with new heart failure (p < 0.05) in 
association with an age-adjusted 16blcalendar decade de- 
cline in the prevalence ofcoronary heart disease among all 
women in the Framingham Heart Study (p < 0.001). 
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!hvivRl after diagnosis ofheart failure, Among the 652 
persons with congestive heart failure, 551 deaths (84.5%) 
occurred. The median survival time after the diagnosis of 
congestive heart failure was 1.66 years in men and 3.17 years 
in women (Table 2) (17). Overall l-year survival rates in men 
and women were 57% and 64%, respectively. The overall 
S-year survival rate was 25% in men and 38% in women. 
There was no significant temporal change in overall survival 
after the diagnosis of congestive heart failure during the 
&year period of observation (age-adjusted male hazards 
ratio for mortality = l.O8/calendar decade, 95% CI 0.92 to 
1.27; age-adjusted female hamds ratio for mortality = 
1.02lcalendar ecade, 95% CI 0.83 to 1.26). After adjusting 
for age, survival after the development of heart failure was 
better in women than in men, with a hazards ratio of 0.64 
(95% CI 0.54 to 0.77). The mortality rate increased with 
advancing age at the diagnosis of heart failure. In men, the 
increase inmortality rate was 27%/decade of age (95% CI 9% 
to 47%). In women, the mortality rate increased by 61%/ 
decade of age (95% confidence interval 37% to 90%). 
Discussion 
Data from the Framingham Heart Study indicate that 
congestive heart failure is more commons in older persons 
and affects approximately 2.5% of the population aged 245 
years. Hypertension preceded the onset of heart failure in 70% 
of men and 78% of women and was associated with a two- to 
four-fold increase in the incidence ofheart failure. Coronary 
heart disease was present in 59% of men and 48% of women 
with heart failure and has been increasing in prevalence among 
new cases of heart failure, Diabetes mehitus and ECG lefi 
ventricular hypertrophy were also associated with a signiti- 
cantly increased incidence of overt congestive heart failure. 
Despite tie increased use of improved therapies for ischemic 
heart disease and hypertension, the age-adjusted incidence of
heart failure has declined by only 1 l%/calendar decade in men 
and by 17% per calendar decade in women during a #year 
period of observation. I  addition, congestive heart failure 
remains highly lethal, with a median survival time of 1.7 years 
Tabte 2. Overall Survival AtIer Congestke Heart Failure as Estimated by Kaplan-Meier Methods 
M&Ill 
Survival Survival Rates 
AU subjects with congestive 
hean failure 
Men 
Women 
Subjects with congestive 
heart failure who 
surv:ved ~90 days 
MCll 
Women 
Subjects Time 
(no.) (yr) 
331 1.66 
321 3.17 
237 3.21 
230 5.39 
90 days 
0.73 
0.72 
e- 
- 
1 Yr 
0.57 
0.64 
0.79 
0.88 
2yr 
0.46 
0.56 
0.63 
0.78 
5 Yr 
0.25 
0.38 
0.35 
0.53 
IO yr 
0.11 
0.21 
0.15 
0.29 
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Table 3. Epidemiologic Studies of Congestive Heart Failure 
Study Group Age tyrt 
Annual CHF 
htcidence 
(per 1.000~ 
Comparable Anuual 
CHF lncidcilce in 
Framingham 
lper l,OOM 
CHF 
Prevalence 
(per LOOM 
Compamble CHF 
Prevalence in 
Framingham 
(per 1,009) 
Tecumseh, Michigan: 1959-1960 (32) 
Men 
Women 
Evans County, Georgia: 1960-1962 (31) 
Men 
Women 
Rural Vermont and North Carolina: 1962-1963 (27) 
Men and women 
Men 
Women 
CZteborg, Sweden: l%3-l9gO (28,291 
Men 
CMteborg, Sweden: 1971-1972 (33) 
Men 
Women 
NHANES-I: 1971-1975 (34) 
Men 
Women 
Framingham: 1980-1988 
Men 
Women 
All ages 2.3* 7* 
845 7.2* 24* 
All ages I .4* 8* 
245 4.7* 25* 
Rochester. Minnesota: 1986 (30) 
Men 
Women 
Eastern Finland: 1986-1988 (26) 
Men 
Women 
235 
235 
45-74 
45-74 
12* 16* 
11* 16* 
4.0-4.2* 4.6* 
l.O-l.6* 2.2* 
*Age-adjusted to the United States 1991 population. Numbers in parentheses indicate reference numbers. CHF = congestive heart failure; NHANRS-I = Fist 
40-79 24= 15* 
40-79 36* 13* 
4f+74 28* 16’ 
45-74 18* is* 
All ages 
All ages 
All ages 
I .4* I.42 
IO' 8* 
II* 6* 
50-54 
55-60 
61-67 
50 
54 
66 
67 
1.5 1.8 
4.3 4.5 
10.2 6.4 
21 7 
24 9 
43 I6 
130 32 
70 110 48 
75 170 50 
70 80 35 
75 110 53 
25-54 8 I 
5>64 45 12 
6W4 48 39 
25-54 13 1 
55-64 30 14 
65-74 43 31 
National Health and Nutrition Examination Survey. 
in men and 3.2 years in women. With 5-year survival rates of 
25% in men and 38% in women, heart failure is associEied with 
a shorter life expectancy than that of many common malignan- 
cies. 
The Framingham Heart Study provides everal unique 
advantages for the study of the epidemiology of congestive 
heart failure. A large unselected patient population with nearly 
equal numbers of men and women was observed for >40 years 
with uniform ascertainment of events. Ah persons with con- 
gestive heart faikn were followed up from the time of diagno- 
sis; in contrast, intervention trials and hospital-based referral 
series utilize selected patients who survived the acute onset of 
congestive h art failure to achieve study entry. 
Other epidemiokygic studies of heart failure. There is no 
agreement on the precise criteria required to establish a
diagnosis ofcongestive h art failure. Most prior heart failure 
intervention trials (18-22) required areduced left ventricular 
ejection fraction as an entry criterion; therefore, their esults 
may be applicable only to patients with systolic heart failure. 
Congestive heart failure has always been defined in the 
Framingham Heart Study on the basis of clinical criteria that 
have been previously validated (23) and are compatible with 
12A HO ET AL. 
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the presence of either diastolic or systolic dysfunction 
(24,22). Gther epidemiologic studies of heart failure have 
used different definitions of heart failure; nonetheless, ome 
of their results are similar to those from Framingham (Table 
3). For example, from 1986 to 1988 in eastern Finland, the 
age-adjusted annual incidence of heart failure among persons 
45 to 74 years old was 4 to 4.2 cases/l,000 in men and 1 .O to 
1.6 cases/l,ooO in women using either the Framingbam or
modiied Boston criteria for heart failure (26). The contp- 
ble annual incidence of congestive h art failure in Framing- 
ham during the 1980s was 4.6 cases/l,000 in men and 2.2 
cases/l,000 in women. Using a simple survey, Gibson et al. 
(27) found that the age-adjusted annual incidence of heart 
failure in two rural counties in 1962 and 1963 was 1.4 
cases/l,000 (adjusted to the U. S. 1991 population); the 
comparably age-adjusted annual incidence of congestive 
heart failure in Framingham in the 1960s was also 1.4 
cases/l,O. The Swedish study (2829) of male residents of 
Giiteborg born in 1913 also reported incidence rates for 
congestive heart failure (using a heart failure score) that are 
very similar to those from Framingham. The prevalence 
rates of heart failure in epidemiologic studies are more 
disparate. The prevalence of heart failure among residents of
Rochester, Minnesota 235 years of age in 1986 was 1.2% in 
men and 1.1% in women (30); the comparable pr valence of
congestive heart failure in Framinghatr in the 1980s was 
1.6% in both men and women. In Evans County, Georgia in 
1960 to 1962, heart failure was found in 2.8% of men and 
1.8% of women aged 45 to 74 years (31); the comparable 
age-srdjusted prevalence in Framingham in the 1960s was 
1.6% in men and 1.5% in women. In Tecumseh, Michigan 
among persons aged 40 to 79 years in 1959 and 1960, the 
age-adjusted prevalence of heart failure was 2.4% in men and 
3.6% in women (32); the respective rates in Framingham 
were 1.5% and 1.3%. Several Swedish studies (28,29,33) 
have used more liberal definitions of heart failure and 
consequently documented prevalence rates of heart failure 
up to four times higher than those in Framingham. 
Over a #year period of observation, the age-adjusted 
incidence of congestive heart failure decreased by ll%/ 
calendar decade in men and by 17%/calendar decade in 
women. Analyses are ongoing to further elucidate th rela- 
tions between the incidence and prevalence of congestive 
heart failure and temporal changes in the prevalence of 
coronary heart disease, valvular heart disease, hyperten- 
sion, diabetes and other conditions. 
!!Jur&al after dlagwsk uf heart falhtre. We were unable 
to detect any significant improvement i  survival after the 
diagnosis of congestive heart failure during the rlO_year 
Period of observation. However, our observational study did 
not directly examine th impact of therapy on survival after 
the onset ofheart failure. In addition, most f he follow-up 
period for our study occurred before the widespread use of 
VaSodi~tOrS, angiotensin-converting enzyme inhibitors and 
heart transplantation. Gf note, our population i cluded per- 
sons who would have been xcluded from many of the recent 
pharmacologic heart failure trials (for example, those pa- 
tients with acute pulmonary edema, unstable angina, recent 
myocardial infarctions or significant valvular heart disease). 
When the analysis was restricted to subjects who survived 
~90 days after the diagnosis of heart failure, a population 
more comparable to those included in intervention trials, the 
median survival time was 3.21 years in men and 5.39 years in 
women. In men, the l-year survival rate was 7% and the 
5-year survival rate was 35%. In women, the l- and S-year 
survival rates were 88% and 53%, respectively. These re- 
sults more closely resemble those from heart failure inter- 
vention trials. For example, the l-, 2- and 4-year survival 
rates for men in the placebo group in the first Veterans 
Administration Cooperative Vasodilator-Heart Failure Trial 
(V-HeFT I) were 81%, 66% and 46910, respectively (19). In 
our study, the corresponding survival rates were 79%, 63% 
ard 45% in men who survived ~90 days after the diagnosis 
of heart failure. 
Concluslons. Despite advances inour therapies for isch- 
emic heart disease and hypertension, congestive heart f il- 
ure remains a common and highly lethal condition. There is 
accumulating evidence that treatment of hypertension a d 
left ventricular systolic dysfunction can decrease the inci- 
dence of clinical congestive heart failure (22,35-37) and that 
use of angiotensin-converting enzyme inhibitors or vasodi- 
lators can prolong survival after the onset of heart failure 
(19~21,38). Clearly, the diagnosis ofcongestive heart failure 
encompasses a constellation of symptoms that can result 
fim a variety of pathophysiologic processes retlectiug both 
systolic and iastolic dysfunction. Improved strategies for 
the prevention and treatment of congestive heart failure 
must take into account he heterogeneous nature of this 
clinical syndrome. 
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